Encompass Health Corp (NYSE:EHC) Expected to Announce Earnings of $0.40 Per Share

Brokerages expect Encompass Health Corp (NYSE:EHC) to announce earnings of $0.40 per share for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Encompass Health’s earnings, with the highest EPS estimate coming in at $0.60 and the lowest estimate coming in at $0.04. Encompass Health reported earnings of $1.08 per share in the same quarter last year, which would indicate a negative year over year growth rate of 63%. The business is scheduled to issue its next quarterly earnings report after the market closes on Monday, July 27th.

On average, analysts expect that Encompass Health will report full-year earnings of $3.08 per share for the current fiscal year, with EPS estimates ranging from $2.79 to $3.31. For the next year, analysts anticipate that the business will report earnings of $4.06 per share, with EPS estimates ranging from $3.84 to $4.19. Zacks’ earnings per share calculations are an average based on a survey of sell-side research analysts that follow Encompass Health.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Tuesday, April 28th. The company reported $0.87 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.87. The business had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.20 billion. Encompass Health had a net margin of 7.36% and a return on equity of 22.00%.

A number of brokerages have weighed in on EHC. Deutsche Bank raised their target price on shares of Encompass Health from $73.00 to $83.00 and gave the company a “hold” rating in a research report on Friday, March 6th. Raymond James cut their target price on shares of Encompass Health from $90.00 to $86.00 and set an “outperform” rating on the stock in a research report on Thursday, April 30th. Mizuho raised their target price on shares of Encompass Health from $87.00 to $90.00 and gave the company a “buy” rating in a research report on Thursday, March 5th. Robert W. Baird raised their target price on shares of Encompass Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, March 5th. Finally, Stephens raised their target price on shares of Encompass Health from $91.00 to $100.00 and gave the company an “overweight” rating in a research report on Thursday, March 5th. Two research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $91.78.

NYSE:EHC traded down $1.22 during mid-day trading on Friday, reaching $59.31. The stock had a trading volume of 1,019,098 shares, compared to its average volume of 771,456. The stock has a 50-day simple moving average of $68.94 and a two-hundred day simple moving average of $70.59. The stock has a market capitalization of $6.02 billion, a PE ratio of 16.23, a P/E/G ratio of 6.94 and a beta of 0.88. The company has a debt-to-equity ratio of 1.98, a current ratio of 1.34 and a quick ratio of 1.34. Encompass Health has a 12 month low of $48.01 and a 12 month high of $83.30.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.28 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.89%. Encompass Health’s dividend payout ratio (DPR) is presently 28.64%.

Encompass Health Company Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Recommended Story: What is the yield curve?

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.